The Department of Otolaryngology – Head and Neck Surgery at the University of California, San Francisco (UCSF OHNS) is pleased to announce that we've retained our top 10 national ranking for NIH grant funding for OHNS departments. This is based on the recently released 2022 National Institutes of Health (NIH) rankings compiled by the Blue Ridge Institute for Medical Research.
UCSF OHNS ranked sixth in the nation and received close to $7.5 million of NIH funding in the department. The UCSF School of Medicine is ranked first among schools of medicine.
"I want to congratulate all of our scientists, and the personnel in the laboratories that they run. Our department is dedicated to innovation. Our Principal Investigators are incredibly talented and fiercely pursue that innovation every day," says Andrew H. Murr, MD, FACS, UCSF OHNS professor and chairman. "Our department's research portfolio is broad and ultimately will impact the care of patients that we see every day in Otolaryngology-Head and Neck Surgery.
The department's portfolio of bench research includes studies in central auditory processing, functional imaging, immunology, stem cell research, cochlear physiology, cancer signaling research, microbiome research and tissue engineering. Our researchers also have impact in work regarding music perception, gender affirmation surgery, olfaction, participation in clinical trials and participation in global surgery initiatives through CHESA.
"Our environment at UCSF is incredibly collaborative and that is perhaps our most powerful hallmark," says Dr. Murr.
UCSF OHNS was ranked #4 in 2020 and 2021. As a university, UCSF maintained a top spot among public institutes in NIH funding for the 16th year in a row. Last year, the School of Medicine was ranked fourth overall nationally among schools of medicine.
Congratulations to the UCSF OHNS and UCSF SOM team!
